Edwards Lifesciences Corp - Asset Resilience Ratio

Latest as of September 2025: 28.95%

Edwards Lifesciences Corp (EW) has an Asset Resilience Ratio of 28.95% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read EW current and long-term liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

$3.84 Billion

Cash + Short-term Investments

Total Assets

$13.27 Billion

All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2007–2024)

This chart shows how Edwards Lifesciences Corp's Asset Resilience Ratio has changed over time. See EW total equity for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Edwards Lifesciences Corp's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see EW market cap.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$2.69 Billion	20.23%
Short-term Investments	$1.16 Billion	8.71%
Total Liquid Assets	$3.84 Billion	28.95%

Asset Resilience Insights

Very High Liquidity: Edwards Lifesciences Corp maintains exceptional liquid asset reserves at 28.95% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Edwards Lifesciences Corp Industry Peers by Asset Resilience Ratio

Compare Edwards Lifesciences Corp's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Demant A/S CO:DEMANT	Medical Devices	-2.59%
Double Medical Technology Inc SHE:002901	Medical Devices	7.79%
Beijing Wandong Medical Technology Co Ltd SHG:600055	Medical Devices	4.92%
Sinocare Inc SHE:300298	Medical Devices	3.53%
MODULIGHT OY EO 1 F:78W	Medical Devices	22.31%
Diagnostic Medical Systems SA PA:ALDMS	Medical Devices	1.39%
Theradiag SA PA:ALTHE	Medical Devices	15.59%
Nova EYE Medical Ltd AU:EYE	Medical Devices	11.08%

Annual Asset Resilience Ratio for Edwards Lifesciences Corp (2007–2024)

The table below shows the annual Asset Resilience Ratio data for Edwards Lifesciences Corp.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	30.45%	$3.98 Billion	$13.06 Billion	+12.89pp
2023-12-31	17.56%	$1.64 Billion	$9.36 Billion	+2.91pp
2022-12-31	14.66%	$1.22 Billion	$8.29 Billion	-2.60pp
2021-12-31	17.25%	$1.47 Billion	$8.50 Billion	-2.13pp
2020-12-31	19.38%	$1.40 Billion	$7.24 Billion	-4.00pp
2019-12-31	23.38%	$1.52 Billion	$6.49 Billion	+5.41pp
2018-12-31	17.97%	$956.50 Million	$5.32 Billion	-5.51pp
2017-12-31	23.48%	$1.34 Billion	$5.70 Billion	-4.70pp
2016-12-31	28.18%	$1.27 Billion	$4.51 Billion	+15.71pp
2015-12-31	12.47%	$506.30 Million	$4.06 Billion	-9.80pp
2014-12-31	22.27%	$785.00 Million	$3.52 Billion	+3.32pp
2013-12-31	18.96%	$516.50 Million	$2.72 Billion	+9.48pp
2012-12-31	9.48%	$210.50 Million	$2.22 Billion	-4.63pp
2011-12-31	14.10%	$279.30 Million	$1.98 Billion	--
2010-12-31	0.00%	$0.00	$1.77 Billion	--
2008-12-31	0.58%	$8.10 Million	$1.40 Billion	-3.09pp
2007-12-31	3.67%	$49.40 Million	$1.35 Billion	--

pp = percentage points

About Edwards Lifesciences Corp

NYSE:EW USA Medical Devices

Market Cap

$48.73 Billion

Market Cap Rank

#589 Global

#284 in USA

Share Price

$83.98

Change (1 day)

+0.57%

52-Week Range

$72.65 - $87.18

All Time High

$130.68